Anti-atherogenic effects of a mixture of ascorbic acid, lysine, proline, arginine, cysteine, and green tea phenolics in human aortic smooth muscle cells

Journal of Cardiovascular Pharmacology

Volumn 49, Issue 3, 2007, Pages 140-145

  Ivanov, Vadim ^a   Roomi, M Waheed ^a   Kalinovsky, T ^a   Niedzwiecki, Aleksandra ^a,b   Rath, Matthias ^a  

^a Dr Rath Research Institute   (United States)

^b NONE   (United States)

Author keywords

Atherosclerosis; Cytokines; Human aortic smooth muscle cell; Matrix metalloproteinases

Indexed keywords

ACETYLCYSTEINE; ANTIATHEROGENIC AGENT; ARGININE; ASCORBIC ACID; CARDIOVASCULAR AGENT; EPIGALLOCATECHIN GALLATE; GELATINASE A; GREEN TEA EXTRACT; INTERLEUKIN 6; LYSINE; MATRIGEL; MONOCYTE CHEMOTACTIC PROTEIN 1; PROLINE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANTIATHEROGENIC ACTIVITY; ANTIINFLAMMATORY ACTIVITY; AORTA; ARTICLE; ATHEROSCLEROSIS; CELL GROWTH; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE RELEASE; DNA SYNTHESIS; DRUG ACTIVITY; DRUG DOSE COMPARISON; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; ENZYME RELEASE; HEART PROTECTION; HUMAN; HUMAN CELL; IMMUNOCHEMISTRY; IN VITRO STUDY; INFLAMMATION; PRIORITY JOURNAL; SMOOTH MUSCLE FIBER; ZYMOGRAPHY;

AMINO ACIDS; ANIMALS; AORTA; ASCORBIC ACID; ATHEROSCLEROSIS; CATECHIN; CATTLE; CELL PROLIFERATION; CELLS, CULTURED; CHEMOKINE CCL2; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; IMMUNOCHEMISTRY; INTERLEUKIN-6; MATRIX METALLOPROTEINASE 2; MYOCYTES, SMOOTH MUSCLE; PHENOLS; PLANT EXTRACTS; TEA;

EID: 34147197189     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/FJC.0b013e3180308489     Document Type: Article

References (21)

1. American Heart Association. American Heart Association Heart Disease and Stroke Statistics-2007 Update. Available at www.heart.org/presenter- jhtml?identifier=3037327.
2. Ross R. The pathogenesis of atherosclerosis-an update. N Engl J Med. 1986;314:488-500.
3. Boscoboinik D, Szewczyk A, Azzi A. Alpha-tocopherol (vitamin E) regulates vascular smooth muscle cell proliferation and protein kinase C activity. Arch Biochem Biophys. 1991;286:264-269.
4. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med. 1999;340:115-26.
5. Geesin JC, Hendricks LJ, Gordon JS, et al. Modulation of collagen synthesis by growth factors: the role of ascorbate-stimulated lipid peroxidation. Arch Biochem Biophys. 1991;289:6-11.
6. Rath M. Solution to the puzzle of human cardiovascular disease: its primary cause is ascorbate deficiency, leading to the deposition of lipoprotein (a) and fibrinogen/fibrin in the vascular wall. J Ortho Med. 1991;6:125-134.
7. Rath M. Reducing the risk for cardiovascular disease with nutritional supplementation. J Ortho Med. 1992;3:1-6.
8. Ivanov V, Ivanova SV, Niedzwiecki A. Ascorbate affects proliferation of guinea-pig vascular smooth muscle cells by direct and extracellular matrix-mediated effects. J Mol Cell Cardiol. 1997;29:3293-3303.
9. Arakawa E, Hasegawa K, Irie J, et al. L-ascorbic acid stimulates expression of smooth muscle-specific markers in smooth muscle cells both in vitro and in vivo. J Cardiovasc Pharmacol. 2003;42:745-751.
10. Miura Y, Chiba T, Tomita I, et al. Tea catechins prevent the development of atherosclerosis in apoprotein E-deficient mice. J Nutr. 2001;131:27-32.
11. Munrad S, Grove D, Lindberg KA, et al. Regulation of collagen synthesis by ascorbic acid. Proc Natl Acad Sci. 1981;78:2879-2882.
12. Rath M. A unified theory of human cardiovascular disease leading the way to the abolition of this disease as a cause for human mortality. J Ortho Med. 1992;7:5-15.
13. Qiao JH, Tripathi J, Mishra K, et al. Role of macrophage colonystimulating factor in atherosclerosis; studies of osteopetrotic mice. Am J Pathol. 1997;150:1687-1699.
14. Gu I, Okada Y, Clinton SK, et al. Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low-density lipoprotein receptor-deficient mice. Mol Cell. 1998;2:275-281.
15. Miura Y, Chiba T, Tomita I, et al. Tea catechins prevent the development of atherosclerosis in apoprotein E-deficient mice. J Nutr. 2001;131:27-32.
16. Riemersma RA, Wood DA, Macintyre CCA, et al. Risk of angina pectoris and plasma concentrations of vitamin A, C, and E and carotene. Lancet. 1991;337:1-5.
17. Hodis HN, Mack WJ, La Bree L, et al. Serial coronary angiographic evidence that antioxidant vitamin intake reduces progression of coronary artery atherosclerosis. JAMA. 1996;275:1893-1896.
18. Netke SP, Roomi MW, Ivanov V, et al. A specific combination of ascorbic acid, lysine, proline and epigallocatechin gallate inhibits proliferation and extracellular matrix invasion of various human cancer cell lines. Res Comm Pharmacol Toxicol Emerg Drugs. 2003;2:37-50.
19. Rath M, Niedzwiecki A. Nutritional supplement halts progression of early coronary atherosclerosis. J Appl Nutr. 1996;48:67-78.
20. Dollery CM, McEwan JR, Henney AM. Matrix metalloproteinases and cardiovascular disease. Circ Res. 1995;77:863-868.
21. Dzau VJ, Ruediger C, Braun-Dullaeus, et al. Vascular proliferation and atherosclerosis: new perspectives and therapeutic strategies. Nat Med. 2002;8:1249-1256.